iPSC-Based Disease Modeling and Drug Screening: An Interview with Paul Tesar and Matthew Elitt

Author unknown

Open source

DOI: 10.1016/j.stemcr.2018.08.020
Published: 09
Container: Stem Cell Reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 4 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.stemcr.2018.08.020,
  title = {iPSC-Based Disease Modeling and Drug Screening: An Interview with Paul Tesar and Matthew Elitt},
  year = {2018},
  journal = {Stem Cell Reports},
  doi = {10.1016/j.stemcr.2018.08.020},
  url = {https://doi.org/10.1016/j.stemcr.2018.08.020}
}

RIS

TY  - JOUR
TI  - iPSC-Based Disease Modeling and Drug Screening: An Interview with Paul Tesar and Matthew Elitt
PY  - 2018
JO  - Stem Cell Reports
DO  - 10.1016/j.stemcr.2018.08.020
UR  - https://doi.org/10.1016/j.stemcr.2018.08.020
ER  -

APA

iPSC-Based Disease Modeling and Drug Screening: An Interview with Paul Tesar and Matthew Elitt. (2018). Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2018.08.020

Source records

doaj · retrieved 2026-09-26T15:31:58.508Z